Stockreport

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

BNB Plus Corp.  (BNBX) 
PDF Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform NEW YORK--(BUSINESS WIRE)--B [Read more]